292 related articles for article (PubMed ID: 35883495)
1. Research Progress of DNA Methylation in Endometrial Cancer.
Xu T; Ding H; Chen J; Lei J; Zhao M; Ji B; Chen Y; Qin S; Gao Q
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883495
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation in endometrial cancer.
Tao MH; Freudenheim JL
Epigenetics; 2010 Aug; 5(6):491-8. PubMed ID: 20543579
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Makabe T; Arai E; Hirano T; Ito N; Fukamachi Y; Takahashi Y; Hirasawa A; Yamagami W; Susumu N; Aoki D; Kanai Y
Carcinogenesis; 2019 Jul; 40(5):611-623. PubMed ID: 30850842
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
Yang T; Qiu H; Bao W; Li B; Lu C; Du G; Luo X; Wang L; Wan X
PLoS One; 2013; 8(6):e67458. PubMed ID: 23840707
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients.
Fialkova V; Vidomanova E; Balharek T; Marcinek J; Kudela E; Hanysova S; Visnovsky J; Dobrota D; Hatok J
Gen Physiol Biophys; 2017 Dec; 36(5):521-529. PubMed ID: 29372685
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.
Bartosch C; Lopes JM; Jerónimo C
Epigenomics; 2017 May; 9(5):737-755. PubMed ID: 28470096
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms in endometrial cancer.
Stampoliou A; Arapantoni-Dadioti P; Pavlakis K
J BUON; 2016; 21(2):301-6. PubMed ID: 27273937
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract][Full Text] [Related]
10. Gene Promoter Methylation in Endometrial Carcinogenesis.
Cornel KMC; Wouters K; Van de Vijver KK; van der Wurff AAM; van Engeland M; Kruitwagen RFPM; Pijnenborg JMA
Pathol Oncol Res; 2019 Apr; 25(2):659-667. PubMed ID: 30430425
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization.
Di Domenico M; Santoro A; Ricciardi C; Iaccarino M; Iaccarino S; Freda M; Feola A; Sanguedolce F; Losito S; Pasquali D; Di Spiezio Sardo A; Bifulco G; Nappi C; Bufo P; Guida M; De Rosa G; Abbruzzese A; Caraglia M; Pannone G
Cancer Biol Ther; 2011 Sep; 12(5):447-57. PubMed ID: 21709441
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of selected genes in endometrial carcinogenesis.
Visnovsky J; Fiolka R; Kudela E; Slavik P; Krkoska M; Lasabová Z; Danko J
Neuro Endocrinol Lett; 2013; 34(7):675-80. PubMed ID: 24464006
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
Muraki Y; Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D
Oncol Rep; 2009 Nov; 22(5):967-72. PubMed ID: 19787208
[TBL] [Abstract][Full Text] [Related]
17. The Relationship between the Methylation of Promoter Regions of Tumor Suppressor Genes PTEN and APC with Endometrial Cancer.
Ghazanfari T; Asaadi Tehrani G; Maziri P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2259-2265. PubMed ID: 31450893
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
[TBL] [Abstract][Full Text] [Related]
19. Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis.
Chen YC; Tsao CM; Kuo CC; Yu MH; Lin YW; Yang CY; Li HJ; Yan MD; Wang TJ; Chou YC; Su HY
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):572-9. PubMed ID: 26522113
[TBL] [Abstract][Full Text] [Related]
20. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
